CRME - Cardiome Pharma Corp.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4255
Avg. Estimate-0.18-0.2-0.82-0.5
Low Estimate-0.2-0.22-0.88-0.81
High Estimate-0.17-0.17-0.770.1
Year Ago EPS-0.17-0.2-0.78-0.82
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts4265
Avg. Estimate8.22M7.8M26.24M40.1M
Low Estimate7.61M7.2M24.5M35.56M
High Estimate8.7M8.4M32.13M47.62M
Year Ago Sales7.02M5.2M25.26M26.24M
Sales Growth (year/est)17.10%50.00%3.90%52.80%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.16-0.16-0.17-0.18
EPS Actual-0.17-0.2-0.26-0.2
Difference-0.01-0.04-0.09-0.02
Surprise %-6.30%-25.00%-52.90%-11.10%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.18-0.2-0.82-0.5
7 Days Ago-0.18-0.2-0.82-0.5
30 Days Ago-0.16-0.16-0.69-0.42
60 Days Ago-0.16-0.16-0.69-0.42
90 Days Ago-0.16-0.16-0.69-0.42
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A11
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesCRMEIndustrySectorS&P 500
Current Qtr.-5.90%N/AN/A0.22
Next Qtr.N/AN/AN/A0.25
Current Year-5.10%N/AN/A0.08
Next Year39.00%N/AN/A0.12
Next 5 Years (per annum)28.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A